A 52-year-old man with dilated cardiomyopathy (ejection fraction 28%) presents with recurrent episodes of non-sustained ventricular tachycardia (NSVT) on 24-hour Holter monitoring. He is on optimal medical therapy including ACE inhibitor, beta-blocker, and aldosterone antagonist. He remains asymptomatic and hemodynamically stable during these episodes. What is the most appropriate next step in management?

Explanation

## Risk Stratification in Dilated Cardiomyopathy with NSVT **Key Point:** NSVT in a patient with severely reduced ejection fraction (EF ≤35%) is a marker of high risk for sudden cardiac death (SCD), even if asymptomatic. This patient meets criteria for ICD placement for primary prevention. **High-Yield:** NSVT + EF ≤35% = ICD indication. NSVT alone (without reduced EF) does not mandate ICD; reduced EF is the key driver of SCD risk in non-ischemic cardiomyopathy. ### ICD Indications in Non-Ischemic Cardiomyopathy | Criterion | EF Threshold | Indication | |-----------|--------------|------------| | Primary prevention (no prior VT/VF) | ≤35% on optimal medical therapy | ICD | | NSVT + reduced EF | ≤35% | ICD (risk stratifier) | | Symptomatic sustained VT | Any EF | ICD | | Prior cardiac arrest (VF/pulseless VT) | Any EF | ICD (secondary prevention) | **Mnemonic:** **EF ≤35% + NSVT = ICD** (in non-ischemic cardiomyopathy on guideline-directed medical therapy) ### Why Not Amiodarone? 1. Amiodarone does NOT reduce mortality in cardiomyopathy with NSVT 2. CAST trial and subsequent trials showed antiarrhythmic drugs increase mortality in structural heart disease 3. ICD is superior for preventing SCD in this population 4. Amiodarone is reserved for symptomatic VT or as adjunct to ICD ### Why Not Increased Beta-Blocker? Beta-blockers are already optimized (patient on guideline-directed medical therapy). Further dose escalation will not prevent VF; ICD is needed. ### Why Not Ablation? EP study with ablation is reserved for: - Incessant VT (continuous or frequent, hemodynamically limiting) - Symptomatic sustained VT refractory to drugs + ICD - Specific identifiable VT focus (scar-related) Asymptomatic NSVT does not warrant ablation as first-line. ```mermaid flowchart TD A[Dilated Cardiomyopathy + NSVT]:::outcome --> B{EF ≤35%?}:::decision B -->|Yes| C[On optimal medical therapy?]:::decision B -->|No| D[Serial monitoring, optimize meds]:::action C -->|Yes| E[ICD for primary prevention]:::action C -->|No| F[Optimize ACEi, BB, MRA]:::action F --> G[Reassess EF in 3 months]:::action E --> H[Reduces SCD risk]:::outcome ``` **Clinical Pearl:** The presence of NSVT in dilated cardiomyopathy is an independent predictor of SCD and warrants ICD placement if EF ≤35%, regardless of symptom status. The arrhythmia substrate (scar, fibrosis) is already established; ICD provides the safety net. [cite:Harrison 21e Ch 226; ACC/AHA 2019 Focused Update on Arrhythmias]